# Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome

> **NCT04303962** · — · UNKNOWN · sponsor: **Ning Wang, MD., PhD.** · enrollment: 200 (estimated)

## Conditions studied

- Guillain-barre Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04303962
- **Lead sponsor:** Ning Wang, MD., PhD.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-27
- **Primary completion:** 2024-01-21
- **Final completion:** 2025-01-21
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04303962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04303962, "Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04303962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*